Trial Parameters
Condition Transplant; Failure, Heart
Sponsor Baylor Research Institute
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2019-09-16
Completion 2030-12
All Conditions
Brief Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Eligibility Criteria
Inclusion Criteria: 1. Recipient of a proven HCV NAT+ donor heart. 2. Re-transplant patients will be included. Exclusion Criteria: 1\. Multi-organ transplantation